Bone cancer in 2011: Prevention and treatment of bone metastases
- PMID: 22182971
- DOI: 10.1038/nrclinonc.2011.198
Bone cancer in 2011: Prevention and treatment of bone metastases
Abstract
Bone-targeting treatments have transformed the quality of life of patients with metastatic bone disease. 2011 saw the emergence of denosumab—a RANK ligand-specific antibody—as a more-effective alternative treatment to bisphosphonates and of data on the use of bone-targeting treatments to prevent metastasis from breast and prostate cancers.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
